|
|
1111 Marcus Avenue, Suite LL26
Lake Success, NY 11042 USA
phone:(516) 333-8230
fax:
|
|
| Symbol |
EZEM |
| Exchange |
Nasdaq |
| Founded |
1961 |
| Employees |
553 |
|
|
| www.ezem.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Products for the screening and diagnosis of diseases related to the gastrointestinal tract |
|
| Management |
| Paul S. Echenberg, Chairman of the Board; Chairman of the Board of E-Z-EM Canada; Anthony A. Lombardo, President, Chief Executive Officer, Director; Dennis J. Curtin, Chief Financial Officer, Senior Vice President; Peter J. Graham, Senior Vice President, Chief Legal Officer, Global Human Resources & Secretary; Brad S. Schreck, Senior Vice President of Sales and Marketingand Engineering; Joseph J. Palma, Senior Vice President- Corporate Relations |
| |
|
|
|
|
|
|
| Recent Results |
| Revenues for FY2006 ended June 2006 increased 22% to $138.4 million. Net income increased 41% to $9,7 million |
| |
|
|
|
|
| Keywords |
| diagnostics, imaging, gastrointestinal, gi, radiography, gastroenterology, colonoscopy, screening, diagnostics, diagnostic imaging, computed tomographjy, ct, virtual colonoscopy, x-ray fluoroscopy, colorectal cancer, cancer screening, swallowing disorders |
|
|
|
| Description |
|
E-Z-EM designs, manufactures, and markets medical products used for colorectal cancer screening, evaluation of swallowing disorders (dysphagia), and testing for other diseases and disorder of the gastrointestinal (GI) tract. |
|
| Products / Services |
The company produces CT injector systems and specialized oral contrast products. E-Z-EM has also developed a complete product set for Virtual Colonoscopy. In gastroenterology, the company develops and markets an expanding line of devices and accessories for endoscopy, unexplained nausea, hydrogen breath testing and other diagnostic needs.
|
|
| Technology / Differentiation |
| CT imaging data is used to crate 2D and 3D images of bone and hard tissue, and soft tissue when contrast media is introduced inside the body. Radiologist typically employ oral and rectal barium sulfate contrast media for thoracic, abdominal and pelvic studies to mark the GI tract. CT examinations are significantly more expensive than X-ray fluoroscopy but the increased information content is thought to outweigh the incremental costs. |
|
| Market / Customers |
The GI market is shifting in favor of early detection and intervention which creates a market opportunity for companies developing imaging technology that can speed detection.
|
|
| Competitors / Substitutes / Alternatives |
Guidant Corp., Mallinckrodt, Schering
|
|
|
|
| |
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members